ShanXi C&Y Pharmaceutical Group Co., Ltd.
SHZ: 300254.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Qun Zhao
- Employees
- 1,234
- Headquarters
- Datong, China
- IPO year
- 2011
- Market cap
- CN¥3.4B
- Website
- https://www.cy-pharm.com
Loading 300254…
Loading profile data…Frequently asked questions about 300254
What does ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) do?
ShanXi C&Y Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China, the United States, Hong Kong, and internationally. It offers products for pregnant women and babies; urinary system products; anti-infection products; traditional Chinese medicines; and dermatology products...
Where does 300254.SZ trade?
ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300254.SZ in?
ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ShanXi C&Y Pharmaceutical Group Co., Ltd.?
Qun Zhao is the chief executive officer of ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ).
Where is ShanXi C&Y Pharmaceutical Group Co., Ltd. headquartered?
ShanXi C&Y Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 300254.SZ pay a dividend?
ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300254.SZ go public?
ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) completed its initial public offering in 2011.